Although we could detect a reduction in PLA, MECP2 and XPC signal (Figure 7B–D) during progression from normal to cancer, we also observed a slight “recovery” of the PLA signal in the cancer samples (SCC in Figure 7B compared to high-grade dysplasias [HGD] lesions). This evidence concerns the gene MECP2 and cancer.